Moody's Derivative Gain (Loss) Excluded from Effectiveness decreased by 100.0% to -$66.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.2%, from -$61.00M to -$66.00M. Over 4 years (FY 2021 to FY 2025), Derivative Gain (Loss) Excluded from Effectiveness shows a downward trend with a 5.6% CAGR.
abbv_derivative_gain_loss_excluded_from_effectiveness| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$49.00M | -$53.00M | -$62.00M | -$53.00M | -$55.00M | -$58.00M | -$65.00M | -$48.00M | -$71.00M | -$66.00M | -$66.00M | -$62.00M | -$63.00M | -$60.00M | -$52.00M | -$61.00M | -$61.00M | -$58.00M | -$33.00M | -$66.00M |
| QoQ Change | — | -8.2% | -17.0% | +14.5% | -3.8% | -5.5% | -12.1% | +26.2% | -47.9% | +7.0% | +0.0% | +6.1% | -1.6% | +4.8% | +13.3% | -17.3% | +0.0% | +4.9% | +43.1% | -100.0% |
| YoY Change | — | — | — | — | -12.2% | -9.4% | -4.8% | +9.4% | -29.1% | -13.8% | -1.5% | -29.2% | +11.3% | +9.1% | +21.2% | +1.6% | +3.2% | +3.3% | +36.5% | -8.2% |